Article may be outdated

This article is 6 days old. Some details may have changed since publication.

Ynetnews·3 min read·medium

World's first once-weekly insulin for type 2 diabetes arrives in Israel

O
Or Hadar
World's first once-weekly insulin for type 2 diabetes arrives in Israel
✦AI Summary

Israel has introduced Awiqli, the world's first once-weekly insulin injection for type 2 diabetes, developed by Novo Nordisk. This treatment significantly reduces the burden of daily injections for patients, though it is currently available only through private purchase.

Why it matters

This medical advancement represents a major shift in diabetes management, potentially improving quality of life and treatment adherence for hundreds of thousands of patients.

✦Dive DeeperCreate a free account to unlock

Good news for patients with type 2 diabetes: Awiqli, the world's first insulin administered in a single weekly injection, is arriving in Israel. Developed by pharmaceutical company Novo Nordisk, the treatment reduces the number of insulin injections from 365 a year to just 52. Initially, it will be available through private purchase, at a price of 280 to 527 shekels per package, depending on the dosage. Each package can last up to 12 weeks. Awiqli was approved in the European Union in 2024 and in the United States in March 2026, and has also been registered in Israel. In September, the U.S. Food and Drug Administration (FDA) approved another weekly insulin, Eli Lilly's Onswik, although it remains unclear when that treatment will become available in Israel. Insulin is a hormone that helps transport sugar from the bloodstream into the body's cells, where it is used for energy.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in